Evidence map›Paper›PMID 24001491›Full record

ReviewMayo Clinic proceedings2013

Role of dietary salt and potassium intake in cardiovascular health and disease: a review of the evidence.

Kristal J Aaron, Paul W Sanders

Registry-linked trialAbstract readReview
In one paragraph

Review in Mayo Clinic proceedings, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07025928 (Salt Intake and Blood Pressure Control in Adults With Essential Hypertension), which is not on this map. Cited by 149 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
149citing papers in PubMed, 5 pooled it
20.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07025928 narecruitingnot on this mapstarted 2026, after this paper: background citation

Salt Intake and Blood Pressure Control in Adults With Essential Hypertension

TypeinterventionalSponsorSun JingfengRan2026 to 2030Enrolled190ConditionsHypertensionArmsDecreased Salt High Potassium Tool (DSHP Tool)
3 · Its place in the literature

Who cites it

149 citing papers in PubMed, 5 syntheses or guidelines pooled it, 356 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Diet and risk of diabetic retinopathy: a systematic review.European journal of epidemiology · 2018
    Pooled it
  6. Trial
  7. Salt sales survey: a simplified, cost-effective method to evaluate population salt reduction programs--a cluster-randomized trial.Hypertension research : official journal of the Japanese Society of Hypertension · 2016
    Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Relationship Between Salt Intake and Cardiovascular Disease.Journal of clinical hypertension (Greenwich, Conn.) · 2025
    Review
  18. Article
  19. Mainstreaming3 Biotech · 2025
    Review
  20. Article

89 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kristal J AaronDepartment of Medicine/Nephrology, University of Alabama at Birmingham, Birmingham, AL, USA.
Paul W Sanders
University of Alabama at Birmingham · US

Funding

UAB-UCSD O'Brien Core Center for Acute Kidney Injury ResearchP30DK079337 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AGARWAL, ANUPAM · 2008 to 2022
$18.3M
UAB Diabetes Research and Training CenterP60DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GARVEY, W TIMOTHY · 2008 to 2012
$8.4M
Salt-Sensitive Hypertension/Hypertensive NephrosclerosisR01DK046199 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SANDERS, PAUL W. · 1992 to 2011
$2.9M
NIDDK NIH HHS P30 DK079337NIDDK NIH HHS P60 DK079626NIDDK NIH HHS R01 DK046199NIDDK NIH HHS R01 DK04699
6 · The paper itself

Abstract

The objective of this review was to provide a synthesis of the evidence on the effect of dietary salt and potassium intake on population blood pressure, cardiovascular disease, and mortality. Dietary guidelines and recommendations are outlined, current controversies regarding the evidence are discussed, and recommendations are made on the basis of the evidence. Designed search strategies were used to search various databases for available studies. Randomized trials of the effect of dietary salt intake reduction or increased potassium intake on blood pressure, target organ damage, cardiovascular disease, and mortality were included. Fifty-two publications from January 1, 1990, to January 31, 2013, were identified for inclusion. Consideration was given to variations in the search terms used and the spelling of terms so that studies were not overlooked, and search terms took the following general form: (dietary salt or dietary sodium or [synonyms]) and (dietary potassium or [synonyms]) and (blood pressure or hypertension or vascular disease or heart disease or chronic kidney disease or stroke or mortality or [synonyms]). Evidence from these studies demonstrates that high salt intake not only increases blood pressure but also plays a role in endothelial dysfunction, cardiovascular structure and function, albuminuria and kidney disease progression, and cardiovascular morbidity and mortality in the general population. Conversely, dietary potassium intake attenuates these effects, showing a linkage to reduction in stroke rates and cardiovascular disease risk. Various subpopulations, such as overweight and obese individuals and aging adults, exhibit greater sensitivity to the effects of reduced salt intake and may gain the most benefits. A diet that includes modest salt restriction while increasing potassium intake serves as a strategy to prevent or control hypertension and decrease cardiovascular morbidity and mortality. Thus, the body of evidence supports population-wide sodium intake reduction and recommended increases in dietary potassium intake as outlined by current guidelines as an essential public health effort to prevent kidney disease, stroke, and cardiovascular disease.

Indexed as

Blood PressureCardiovascular DiseasesCardiovascular SystemDietHumansHypertensionPotassium, DietarySodium, DietaryStrokePotassium, DietarySodium, Dietaryblood pressureBPcardiovascular diseasechronic kidney diseaseCKDCVDDASHDietary Approaches to Stop Hypertensionrandomized controlled trialRCTUNaurinary sodium

Identifiers

PMID24001491
PMCPMC3833247
OpenAlexW2074741498

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.